Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 11

Publication Record


Dietary polyunsaturated fatty acids and incidence of end-stage renal disease in the Southern Community Cohort Study.
Malhotra R, Cavanaugh KL, Blot WJ, Ikizler TA, Lipworth L, Kabagambe EK
(2016) BMC Nephrol 17: 152
MeSH Terms: Adult, Aged, Diet Records, Dietary Fats, Unsaturated, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Female, Humans, Incidence, Kidney Failure, Chronic, Male, Middle Aged, Odds Ratio, Prospective Studies, Southeastern United States
Show Abstract · Added October 21, 2016
BACKGROUND - Whether polyunsaturated fatty acids (PUFA) are associated with end-stage renal disease (ESRD) in populations with a high burden of risk factors for kidney disease is unknown. We sought to determine whether PUFA intake is associated with ESRD.
METHODS - We conducted a nested case-control study of ESRD within the Southern Community Cohort Study (SCCS), a prospective cohort of low-income blacks and whites in the southeastern US (2002-2009). Through 2012, 1,074 incident ESRD cases were identified by linkage with the United States Renal Data System and matched to 3,230 controls by age, sex and race. Dietary intake of total, n-3 or n-6 PUFA was assessed from a validated food frequency questionnaire administered at baseline. Odds ratios (ORs) and 95 % confidence intervals (CIs) were computed from logistic regression models that included matching variables, body mass index, smoking, diabetes, hypertension, education, income, total energy intake and percent energy from protein and saturated fat.
RESULTS - The mean (SD) age of participants was 55 (9) years. Most participants were women (55 %), black (87 %), with hypertension (67 %) and on average obtained 8 % of their energy from PUFA. Higher PUFA intake was marginally associated with a lower risk of ESRD in adjusted analyses. The adjusted odds ratios (95 % confidence intervals) for ESRD for the 5 vs. 1 quintile of PUFA were 0.79 (0.60-1.05; P  = 0.06) for total PUFA, 0.81 (0.61-1.06; P  = 0.04) for n-6 PUFA and 0.93 (0.71-1.21; P  = 0.45) for n-3 PUFA.
CONCLUSIONS - We observed a marginally significant inverse trend between dietary PUFA intake and ESRD incidence, mainly driven by n-6 fatty acid intake. Our findings require replication but suggest that a diet rich in n-6 PUFA may prevent ESRD development in a population with a high burden of kidney disease risk factors.
0 Communities
1 Members
0 Resources
15 MeSH Terms
Plasma n-6 Fatty Acid Levels Are Associated With CD4 Cell Counts, Hospitalization, and Mortality in HIV-Infected Patients.
Kabagambe EK, Ezeamama AE, Guwatudde D, Campos H, Fawzi W
(2016) J Acquir Immune Defic Syndr 73: 598-605
MeSH Terms: Adult, CD4 Lymphocyte Count, Fatty Acids, Omega-6, Female, Gas Chromatography-Mass Spectrometry, HIV Infections, Hospitalization, Humans, Male, Middle Aged, Plasma, Risk Assessment, Survival Analysis, Uganda
Show Abstract · Added September 17, 2016
BACKGROUND - Fatty acids, including n-6 series, modulate immune function, but their effect on CD4 cell counts, death, or hospitalization in HIV-infected patients on antiretroviral therapy is unknown.
METHODS - In a randomized trial for effects of multivitamins in HIV-infected patients in Uganda, we used gas chromatography to measure plasma n-6 fatty acids at baseline; determined CD4 counts at baseline, 3, 6, 12, and 18 months; and recorded hospitalization or death events. The associations of fatty acids with CD4 counts and events were analyzed using repeated-measures analysis of variance and Cox regression, respectively.
RESULTS - Among 297 patients with fatty acids measurements, 16 patients died and 69 were hospitalized within 18 months. Except for linoleic acid, n-6 fatty acids levels were positively associated with CD4 counts at baseline but not during follow-up. In models that included all 5 major n-6 fatty acids, age; sex; body mass index; anemia status; use of antiretroviral therapy, multivitamin supplements, and alcohol; and the risk of death or hospitalization decreased significantly with an increase in linoleic acid and gamma-linolenic acid levels, whereas associations for dihomo-gamma-linolenic acid, arachidonic acid, and aolrenic acid were null. The hazard ratios (95% confidence intervals) per 1 SD increase in linoleic acid and gamma-linolenic acid were 0.73 (0.56-0.94) and 0.51 (0.36-0.72), respectively. Gamma-linolenic acid remained significant (hazard ratio = 0.51; 95% confidence interval: 0.35 to 0.68) after further adjustment for other plasma fatty acids.
CONCLUSIONS - Lower levels of gamma-linolenic acid are associated with lower CD4 counts and an increased risk of death or hospitalization. These results suggest a potential for using n-6 fatty acids to improve outcomes from antiretroviral therapy.
0 Communities
1 Members
0 Resources
14 MeSH Terms
Intake of polyunsaturated fat in relation to mortality among statin users and non-users in the Southern Community Cohort Study.
Kiage JN, Sampson UK, Lipworth L, Fazio S, Mensah GA, Yu Q, Munro H, Akwo EA, Dai Q, Blot WJ, Kabagambe EK
(2015) Nutr Metab Cardiovasc Dis 25: 1016-24
MeSH Terms: Adult, Animals, Blood Pressure, Body Mass Index, Cardiovascular Diseases, Cohort Studies, Diet, Energy Intake, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Female, Fishes, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Male, Middle Aged, Primary Prevention, Proportional Hazards Models, Prospective Studies, Seafood, Socioeconomic Factors
Show Abstract · Added February 18, 2016
BACKGROUND AND AIMS - Consumption of polyunsaturated fatty acids (PUFA), especially the n3-series, may protect against cardiovascular disease (CVD), but recent randomized studies have failed to demonstrate these benefits. One of the prevailing hypotheses is that PUFA intake may not confer benefits beyond those provided by statins, but studies comparing statin users to non-users with regard to effects of PUFA are lacking.
METHODS AND RESULTS - Black and white men and women (n = 69,559) in the Southern Community Cohort Study were studied. Cox regression models adjusting for age, sex, race, BMI, recruitment site, education, income, smoking, diabetes, and dietary variables were used.
RESULTS - At baseline the mean ± SD age was 52 ± 9 years, 60% of participants were women, 54% had hypertension and 16% used statins. We observed modest inverse associations between n3-PUFA and n6-PUFA intake with mortality among non-statin users but not among statin users. In adjusted analyses, the HRs (95% CIs) for all-cause mortality (6,396 deaths over a median of 6.4 years) comparing the highest to the lowest quintile were 0.90 (0.82-1.00) for n3-PUFA and 0.80 (0.70-0.92) for n6-PUFA among non-statin users, whereas they were 1.06 (0.87-1.28) and 0.96 (0.78-1.19) for n3-PUFA and n6-PUFA, respectively, among statin users.
CONCLUSIONS - Our results suggest potential benefits of PUFA consumption on mortality which are only apparent in the absence of statin therapy. It seems prudent to consider the potential benefit of PUFA consumption in the primary prevention of CVD among patients who are not candidates for statin therapy but are at increased risk for CVD and mortality.
Copyright © 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. All rights reserved.
0 Communities
2 Members
0 Resources
21 MeSH Terms
Genetic loci associated with circulating phospholipid trans fatty acids: a meta-analysis of genome-wide association studies from the CHARGE Consortium.
Mozaffarian D, Kabagambe EK, Johnson CO, Lemaitre RN, Manichaikul A, Sun Q, Foy M, Wang L, Wiener H, Irvin MR, Rich SS, Wu H, Jensen MK, Chasman DI, Chu AY, Fornage M, Steffen L, King IB, McKnight B, Psaty BM, Djoussé L, Chen IY, Wu JH, Siscovick DS, Ridker PM, Tsai MY, Rimm EB, Hu FB, Arnett DK
(2015) Am J Clin Nutr 101: 398-406
MeSH Terms: African Americans, Arachidonic Acid, Asian Americans, Biomarkers, European Continental Ancestry Group, Fatty Acids, Omega-6, Gene Frequency, Genetic Association Studies, Genetic Loci, Genotyping Techniques, Humans, Phospholipids, Polymorphism, Single Nucleotide, Trans Fatty Acids
Show Abstract · Added April 23, 2015
BACKGROUND - Circulating trans fatty acids (TFAs), which cannot be synthesized by humans, are linked to adverse health outcomes. Although TFAs are obtained from diet, little is known about subsequent influences (e.g., relating to incorporation, metabolism, or intercompetition with other fatty acids) that could alter circulating concentrations and possibly modulate or mediate impacts on health.
OBJECTIVE - The objective was to elucidate novel biologic pathways that may influence circulating TFAs by evaluating associations between common genetic variation and TFA biomarkers.
DESIGN - We performed meta-analyses using 7 cohorts of European-ancestry participants (n = 8013) having measured genome-wide variation in single-nucleotide polymorphisms (SNPs) and circulating TFA biomarkers (erythrocyte or plasma phospholipids), including trans-16:1n-7, total trans-18:1, trans/cis-18:2, cis/trans-18:2, and trans/trans-18:2. We further evaluated SNPs with genome-wide significant associations among African Americans (n = 1082), Chinese Americans (n = 669), and Hispanic Americans (n = 657) from 2 of these cohorts.
RESULTS - Among European-ancestry participants, 31 SNPs in or near the fatty acid desaturase (FADS) 1 and 2 cluster were associated with cis/trans-18:2; a top hit was rs174548 (β = 0.0035, P = 4.90 × 10(-15)), an SNP previously associated with circulating n-3 and n-6 polyunsaturated fatty acid concentrations. No significant association was identified for other TFAs. rs174548 in FADS1/2 was also associated with cis/trans-18:2 in Hispanic Americans (β = 0.0053, P = 1.05 × 10(-6)) and Chinese Americans (β = 0.0028, P = 0.002) but not African Americans (β = 0.0009, P = 0.34); however, in African Americans, fine mapping identified a top hit in FADS2 associated with cis/trans-18:2 (rs174579: β = 0.0118, P = 4.05 × 10(-5)). The association between rs174548 and cis/trans-18:2 remained significant after further adjustment for individual circulating n-3 and n-6 fatty acids, except arachidonic acid. After adjustment for arachidonic acid concentrations, the association between rs174548 and cis/trans-18:2 was nearly eliminated in European-ancestry participants (β-coefficient reduced by 86%), with similar reductions in Hispanic Americans and Chinese Americans.
CONCLUSIONS - Our findings provide novel evidence for genetic regulation of cis/trans-18:2 by the FADS1/2 cluster and suggest that this regulation may be influenced/mediated by concentrations of arachidonic acid, an n-6 polyunsaturated fat.
© 2015 American Society for Nutrition.
0 Communities
1 Members
0 Resources
14 MeSH Terms
Genetic variations at the lipoprotein lipase gene influence plasma lipid concentrations and interact with plasma n-6 polyunsaturated fatty acids to modulate lipid metabolism.
Garcia-Rios A, Delgado-Lista J, Perez-Martinez P, Phillips CM, Ferguson JF, Gjelstad IM, Williams CM, Karlström B, Kieć-Wilk B, Blaak EE, Lairon D, Planells R, Malczewska-Malec M, Defoort C, Riserus U, Saris WH, Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J
(2011) Atherosclerosis 218: 416-22
MeSH Terms: Adult, Aged, Alleles, Cohort Studies, Europe, Fatty Acids, Omega-6, Gene Expression Regulation, Enzymologic, Genetic Variation, Heterozygote, Homozygote, Humans, Lipid Metabolism, Lipids, Lipoprotein Lipase, Metabolic Syndrome, Middle Aged, Polymorphism, Single Nucleotide, Triglycerides
Show Abstract · Added January 20, 2015
OBJECTIVE - To investigate whether seven common single nucleotide polymorphisms (SNPs) at the lipoprotein lipase (LPL) locus interact with total plasma fatty acids to modulate plasma lipid metabolism in metabolic syndrome (MetS) patients.
METHODS - Plasma fatty acid composition, plasma lipid concentrations and LPL SNPs were determined in 452 subjects with the MetS in the European LIPGENE human study and were repeated in 1754 subjects from the LIPGENE-SU.VI.MAX Study.
RESULTS - Triglycerides (TG) were lower, and HDL higher in the carriers of rs328 and rs1059611 in the SUVIMAX cohort (all P<0.001), and these findings showed a similar, non-significant trend in LIPGENE cohort. In this last cohort, we found a gene-fatty acids interaction, as the carriers of the minor allele displayed a lower fasting TG and triglyceride rich lipoproteins-TG (TRL-TG) concentrations only when they had n-6 polyunsaturated fatty acids below the median (all P<0.05). Moreover, subjects carrying the minor allele for rs328 SNP and with a low level of n-6 PUFA displayed higher nonesterified fatty acid (NEFA) plasma concentrations as compared with homozygous for the major allele (P=0.034). Interestingly, the n-6 PUFA-dependent associations between those SNPs and TG metabolism were also replicated in subjects without MetS from the SU.VI.MAX cohort.
CONCLUSION - Two genetic variations at the LPL gene (rs328 and rs1059611) influence plasma lipid concentrations and interact with plasma n-6 PUFA to modulate lipid metabolism. The knowledge of new genetic factors together with the understanding of these gene-nutrient interactions could help to a better knowledge of the pathogenesis in the MetS.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
0 Communities
1 Members
0 Resources
18 MeSH Terms
Dietary polyunsaturated fatty acids and breast cancer risk in Chinese women: a prospective cohort study.
Murff HJ, Shu XO, Li H, Yang G, Wu X, Cai H, Wen W, Gao YT, Zheng W
(2011) Int J Cancer 128: 1434-41
MeSH Terms: Adult, Aged, Breast Neoplasms, China, Cohort Studies, Dietary Fats, Unsaturated, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Female, Follow-Up Studies, Humans, Middle Aged, Prognosis, Prospective Studies, Risk Factors, Surveys and Questionnaires
Show Abstract · Added March 5, 2014
Breast cancer is the most common cancer in women. Controversy exists regarding the role of dietary fat in breast cancer etiology. We investigated the association of dietary polyunsaturated fatty acids (PUFAs) and the ratio of n-6 PUFAs to marine-derived n-3 PUFAs with breast cancer risk in the Shanghai Women's Health Study, a prospective cohort study including 72,571 cancer-free participants at baseline. Dietary fatty acid intake was determined using food frequency questionnaires. We used Cox proportional hazards analysis to estimate the relative risks (RRs) and 95% confidence intervals (CIs) for the association of breast cancer risk with dietary fatty acids consumption. In 583,998 person-years of follow-up, we identified 712 breast cancer cases. We found no association of breast cancer risk to dietary intake of linoleic acid, arachidonic acid, α-linolenic acid or marine-derived n-3 PUFA. We found a statistically significant interaction between n-6 PUFA intake, marine-derived n-3 PUFA intake and breast cancer risk (p = 0.008). Women with lower intake (the lowest tertile) of marine-derived n-3 PUFA and higher intake (the highest tertile) of n-6 PUFA had an increase risk for breast cancer (RR = 2.06; 95% CI = 1.27-3.34) compared to women with higher intake (the highest tertile) of marine-derived n-3 PUFAs and lower intake (the lowest tertile) of n-6 PUFAs after adjusting for potential confounders. The relative amounts of n-6 PUFA to marine-derived n-3 PUFAs may be more important for breast cancer risk than individual dietary amounts of these fatty acids.
Copyright © 2010 UICC.
0 Communities
3 Members
0 Resources
16 MeSH Terms
ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study.
Junyent M, Parnell LD, Lai CQ, Arnett DK, Tsai MY, Kabagambe EK, Straka RJ, Province M, An P, Smith CE, Lee YC, Borecki I, Ordovás JM
(2010) Nutr Metab Cardiovasc Dis 20: 698-705
MeSH Terms: ADAM Proteins, ADAM17 Protein, Adipocytes, Adult, Aged, Alleles, Body Mass Index, Cholesterol, HDL, Diet, Dietary Fats, Unsaturated, Fatty Acids, Omega-6, Female, Genetic Predisposition to Disease, Genotype, Humans, Insulin, Insulin Resistance, Logistic Models, Male, Middle Aged, Obesity, Polymorphism, Single Nucleotide
Show Abstract · Added April 23, 2015
BACKGROUND AND AIMS - The disintegrin and metalloproteinase ADAM17, also known as tumor necrosis factor alpha converting enzyme, is expressed in adipocytes. Importantly, elevated levels of ADAM17 expression have been linked to obesity and insulin resistance. Therefore, the aim of this study was to evaluate the association of six ADAM17 single nucleotide polymorphisms (SNPs) (m1254A>G, i14121C>A, i33708A>G, i48827A>C, i53440C>T, and i62781G>T) with insulin-resistance phenotypes and obesity risk, and their potential interactions with dietary polyunsaturated fatty acids (PUFA).
METHODS AND RESULTS - ADAM17 SNPs were genotyped in 936 subjects (448 men/488 women) who participated in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study. Anthropometrical and biochemical measurements were determined by standard procedures. PUFA intake was estimated using a validated questionnaire. G allele carriers at the ADAM17_m1254A>G polymorphism exhibited significantly higher risk of obesity (P=0.003), were shorter (P=0.017), had higher insulin (P=0.016), and lower HDL-C concentrations (P=0.027) than AA subjects. For the ADAM17_i33708A>G SNP, homozygotes for the A allele displayed higher risk of obesity (P=0.001), were heavier (P=0.011), had higher BMI (P=0.005), and higher waist measurements (P=0.023) than GG subjects. A significant gene-diet interaction was found (P=0.030), in which the deleterious association of the i33708A allele with obesity was observed in subjects with low intakes from (n-6) PUFA (P<0.001), whereas no differences in obesity risk were seen among subjects with high (n-6) PUFA intake (P>0.5)
CONCLUSION - These findings support that ADAM17 (m1254A>G and i33708A>G) SNPs may contribute to obesity risk. For the ADAM17_i33708A>G SNP, this risk may be further modulated by (n-6) PUFA intake.
Copyright © 2009 Elsevier B.V. All rights reserved.
0 Communities
1 Members
0 Resources
22 MeSH Terms
Nonpharmacologic treatment of dyslipidemia.
Houston MC, Fazio S, Chilton FH, Wise DE, Jones KB, Barringer TA, Bramlet DA
(2009) Prog Cardiovasc Dis 52: 61-94
MeSH Terms: Animals, Antioxidants, Aquaculture, Cardiovascular Diseases, Cholesterol, LDL, Diabetes Mellitus, Type 2, Diabetic Angiopathies, Diet, Dyslipidemias, Eicosanoids, Exercise, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Fatty Acids, Unsaturated, Fishes, Herbal Medicine, Humans, Hypolipidemic Agents, Life Style, Niacin, Nutrition Therapy, Oxygen Consumption, Seafood, Soybean Proteins, Tocotrienols
Added December 10, 2013
0 Communities
1 Members
0 Resources
25 MeSH Terms
Substituent effects on regioselectivity in the autoxidation of nonconjugated dienes.
Tallman KA, Rector CL, Porter NA
(2009) J Am Chem Soc 131: 5635-41
MeSH Terms: Alkenes, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Free Radicals, Hydrogen Peroxide, Oxidants, Oxidation-Reduction, alpha-Tocopherol
Show Abstract · Added March 7, 2014
Free radical oxidation of several 1,4-dienes was carried out in the presence of variable concentrations of alpha-tocopherol to investigate the effect of diene structure on product distribution. Oxidations carried out at low tocopherol concentration gave only C-1 and C-5 conjugated diene hydroperoxides, while higher concentrations of the antioxidant resulted in formation of substantial amounts of the nonconjugated C-3 diene hydroperoxide. Increasing size of the substituents at C-1 and C-5 of the diene favors kinetic products arising from oxygen addition at the nonconjugated position, C-3, of the pentadienyl radical intermediate. Substituents at C-1 or C-5 of the pentadienyl radical also have a significant effect on the regioselectivity of the conjugated diene hydroperoxides formed, larger substituents directing oxygen addition to the pentadienyl radical at the site of least steric hindrance. This trend is also observed in oxidations of omega-3 and omega-6 linolenate fatty acid esters. Groups at C-1 and C-5 of the diene can influence product distribution based upon (a) steric demand in the oxygen-radical reaction and (b) the influence of substituents on the rearrangement of the C-3 peroxyl radical to give conjugated diene products.
0 Communities
1 Members
0 Resources
8 MeSH Terms
Adipose tissue biomarkers of fatty acid intake.
Baylin A, Kabagambe EK, Siles X, Campos H
(2002) Am J Clin Nutr 76: 750-7
MeSH Terms: Adipose Tissue, Aged, Animals, Biomarkers, Costa Rica, Dairy Products, Diet, Diet Records, Dietary Fats, Energy Intake, Fatty Acids, Fatty Acids, Omega-3, Fatty Acids, Omega-6, Fatty Acids, Unsaturated, Female, Fishes, Humans, Linoleic Acid, Male, Middle Aged, Surveys and Questionnaires, alpha-Linolenic Acid
Show Abstract · Added April 24, 2015
BACKGROUND - Biomarkers can provide a more accurate measure of long-term intake than can dietary questionnaires.
OBJECTIVE - The objective was to identify which adipose tissue fatty acids are suitable biomarkers of intake as assessed with a validated food-frequency questionnaire.
DESIGN - Costa Rican men with a mean (+/- SD) age of 56 +/- 11 y (n = 367) and women aged 60 +/- 10 y (n = 136) completed a 135-item food-frequency questionnaire and provided an adipose tissue sample. Fifty fatty acids were identified by capillary gas chromatography. Correlation coefficients were calculated after adjustment for age, sex, body mass index, and smoking status.
RESULTS - The best adipose tissue marker for total intake of saturated fatty acids was 15:0 + 17:0 (r = 0.18). Both 15:0 and 17:0 were also the best correlates of dairy product intake (r = 0.31 for each). The diet-adipose tissue correlations for n-3 fatty acids were r = 0.34 for 18:3, r = 0.15 for 20:5, and r = 0.18 for 22:6. Fish intake correlated significantly with these adipose tissue n-3 fatty acids. Dietary and adipose tissue n-6 fatty acids were highly correlated: 18:2 (r = 0.58) and 18:3 (r = 0.24). The best indicators of total trans fatty acid intake were ct18:2n-6 and tc18:2n-6 (r = 0.58 for each); total 18:1 trans fatty acid (r = 0.45) and 16:1 trans fatty acid (r = 0.16) were the next best indicators.
CONCLUSIONS - Adipose tissue is a suitable biomarker of dietary fatty acid intake, particularly for n-3 and n-6 cis polyunsaturated fatty acids and trans fatty acids. Ideally, adipose tissue and dietary questionnaires should complement, rather than substitute for, each other in epidemiologic studies.
0 Communities
1 Members
0 Resources
22 MeSH Terms